Skip to content
S1652Senate2019-2020 SessionSame asA6757

Treat Fentanyl Analogues as Opiates

Official title

“Provides that a fentanyl analogue shall be deemed to be a schedule I opiate”

Sponsor James SkoufisSD-39+5 co-sponsorsAffects Health
Status
In Senate Committee
Health
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill adds fentanyl analogues to controlled substances and clarifies that knowledge of their chemical structure is not required for prosecution.

Why it matters

  1. Expands the scope of controlled substances. By broadly defining "fentanyl analogue" to include any substance structurally related to fentanyl (with specific chemical modifications), the bill targets a wide range of synthetic opioids that criminals may create to evade existing drug laws.

  2. Closes legal loopholes for prosecution. The bill explicitly states that prosecutors do not need to prove a defendant knew the exact chemical structure of a fentanyl analogue, making it easier to hold traffickers and dealers accountable even if they claim ignorance of a drug's precise composition.

  3. Limits impact on legitimate research and medicine. The bill exempts FDA-approved drugs and substances used under authorized medical research, aiming to focus enforcement on illegal drug activity without hindering medical innovation or patient access to approved treatments.

  4. Addresses public health and safety concerns. By rapidly scheduling new fentanyl-like substances as controlled, the legislation seeks to combat the ongoing opioid overdose crisis, as fentanyl analogues have been linked to a surge in accidental deaths.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Treat Fentanyl Analogues as Opiates

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
James Skoufis

Senator · Senate District 39

Chair, Investigations And Government Operations

History

  1. Referred to health
  2. Returned to senate
  3. Died in assembly
  4. Referred to health
  5. Delivered to assembly
  6. Passed senateVote 58–0
  7. Ordered to third reading cal.993
  8. Committee discharged and committed to rules
  9. Print number 1652a
  10. Amend (t) and recommit to health
  11. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A6757Assembly

Classify Fentanyl Analogues Schedule I

In Assembly Committee · Health · Sponsor Michael Cusick

Impact 7 · Significant0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

1652--A

2019-2020 Regular Sessions

IN SENATE

January 15, 2019

Introduced by Sens. SKOUFIS, BIAGGI, BOYLE, MAYER, PARKER -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the public health law and the penal law, in relation to fentanyl analogues

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 3302 of the public health law is amended by adding a new subdivision 44 to read as follows:

44. "Fentanyl analogue" (a) means any substance that is structurally related to fentanyl by one or more of the following modifications:

(i) replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;

(ii) substation in or on the phenethyl group with alkl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups;

(iii) substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nito groups;

(iv) replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocylce; and/or

(v) replacement of the N-propionyl group by another acyl group.

(b) such term shall not include:

(i) fentanyl;

(ii) any substance for which there is an approved new drug application by the Federal Food and Drug Administration (FDA); or

(iii) with respect to a particular person, any substance, if an exemption is in effect for investigational use for that person, as provided by 21 U.S.C. § 355, to the extent conduct with respect to the substance is pursuant to such exemption.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD06553-02-9

S. 1652--A 2

§ 2.Subdivision (b) of schedule I of section 3306 of the public health law is amended by adding a new paragraph 58 to read as follows:

58. Any fentanyl analogue.

§ 3. Section 220.00 of the penal law is amended by adding a new subdivision 21 to read as follows:

21. "Knowingly" when used in connection with an offense involving the possession or sale, or the attempt or conspiracy to possess or sell a fentanyl analogue, shall not require knowledge by a person of the chemical structure of the substance.

§ 4. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law and the penal law, in relation to fentanyl analogues

Purpose

To define fentanyl analogues and make them subject to section 3306 of the public health law to aid in criminal prosecution of individuals who sell fentanyl analogues

Summary of provisions

Section 1: Amends Section 3302 of the public health law to add a defi- nition of "fentanyl analogue"

Section 2: Adds a new section to the public health law regarding fenta- nyl analogues

Section 3: Amends Section 220.00 of the penal law to clarify that for offenses involving the possession or sale of a fentanyl analogue, an individual can commit a crime "knowingly" even if he or she does not have knowledge of the exact chemical structure of the fentanyl analogue.

Section 4: Effective Date.

Justification

Synthetic fentanyl-like drugs that mimic the effects of fentanyl but have different chemical structures are increasingly being sold to indi- viduals in New York State. These synthetic fentanyl analogues often have medical effects that are similar to or greater than fentanyl, but are not adequately regulated by existing state law. This bill addresses these deficiencies and gives prosecutors stronger ability to prosecute those who threaten the health and well-being of New Yorkers.

Legislative history

None.

Fiscal implications

None.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.